» Articles » PMID: 34536346

Genomic and Functional Characterization of a Mucosal Symbiont Involved in Early-stage Colorectal Cancer

Abstract

Colorectal cancer is a major health concern worldwide. Growing evidence for the role of the gut microbiota in the initiation of CRC has sparked interest in approaches that target these microorganisms. However, little is known about the composition and role of the microbiota associated with precancerous polyps. Here, we found distinct microbial signatures between patients with and without polyps and between polyp subtypes using sequencing and culturing techniques. We found a correlation between Bacteroides fragilis recovered and the level of inflammatory cytokines in the mucosa adjacent to the polyp. Additional analysis revealed that B. fragilis from patients with polyps are bft-negative, activate NF-κB through Toll-like receptor 4, induce a pro-inflammatory response, and are enriched in genes associated with LPS biosynthesis. This study provides fundamental insight into the microbial microenvironment of the pre-neoplastic polyp by highlighting strain-specific genomic and proteomic differences, as well as more broad compositional differences in the microbiome.

Citing Articles

Uniform bacterial genetic diversity along the guts of mice inoculated with human stool.

Wasney M, Briscoe L, Wolff R, Ghezzi H, Tropini C, Garud N bioRxiv. 2025; .

PMID: 39974986 PMC: 11838389. DOI: 10.1101/2025.01.28.635365.


inhibits the progression of colorectal tumorigenesis in mice through fatty acid isomerization and gut microbiota modulation.

Chen Y, Fang H, Chen H, Liu X, Zhao J, Stanton C Gut Microbes. 2025; 17(1):2464945.

PMID: 39924893 PMC: 11812354. DOI: 10.1080/19490976.2025.2464945.


Combinatorial phenotypic landscape enables bacterial resistance to phage infection.

Gupta A, Morella N, Sutormin D, Li N, Gaisser K, Robertson A bioRxiv. 2025; .

PMID: 39868116 PMC: 11761130. DOI: 10.1101/2025.01.13.632860.


Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation.

Kordahi M, Daniel N, Gewirtz A, Chassaing B Gut Microbes. 2025; 17(1):2455790.

PMID: 39865067 PMC: 11776472. DOI: 10.1080/19490976.2025.2455790.


Impact of gut microbiota and its metabolites on immunometabolism in colorectal cancer.

Flory M, Bravo P, Alam A Immunometabolism (Cobham). 2024; 6(4):e00050.

PMID: 39624362 PMC: 11608621. DOI: 10.1097/IN9.0000000000000050.


References
1.
Mager L, Wasmer M, Rau T, Krebs P . Cytokine-Induced Modulation of Colorectal Cancer. Front Oncol. 2016; 6:96. PMC: 4835502. DOI: 10.3389/fonc.2016.00096. View

2.
Andersen V, Holst R, Kopp T, Tjonneland A, Vogel U . Interactions between diet, lifestyle and IL10, IL1B, and PTGS2/COX-2 gene polymorphisms in relation to risk of colorectal cancer in a prospective Danish case-cohort study. PLoS One. 2013; 8(10):e78366. PMC: 3806836. DOI: 10.1371/journal.pone.0078366. View

3.
Bolger A, Lohse M, Usadel B . Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014; 30(15):2114-20. PMC: 4103590. DOI: 10.1093/bioinformatics/btu170. View

4.
Masucci M, Minopoli M, Carriero M . Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy. Front Oncol. 2019; 9:1146. PMC: 6874146. DOI: 10.3389/fonc.2019.01146. View

5.
Chatzidaki-Livanis M, Geva-Zatorsky N, Comstock L . Bacteroides fragilis type VI secretion systems use novel effector and immunity proteins to antagonize human gut Bacteroidales species. Proc Natl Acad Sci U S A. 2016; 113(13):3627-32. PMC: 4822612. DOI: 10.1073/pnas.1522510113. View